Literature DB >> 12242854

Use of an insulin pen by homeless patients with diabetes mellitus.

Terry Wilk1, Pablo F Mora, Susan Chaney, Kathleen Shaw.   

Abstract

PURPOSE: To assess the impact of an insulin delivery system, the NovoPen, on diabetes treatment for the homeless. DATA SOURCES: Homeless patients (n = 23) with diabetes and using insulin were identified from a registry of patients with diabetes maintained at the Homeless Outreach Medical Services clinical sites. Baseline evaluations included glycosylated hemoglobin (HbA1c) measurements and a questionnaire about the patient's current treatment practices. Patients were instructed in the use of the NovoPen; HbA1c measurements and questionnaires were repeated after 3 and 6 months of participation.
CONCLUSIONS: Reductions of HbA1c were observed at 3 and 6 months. The authors concluded that use of the pen improved patient compliance and thus glycemic control. IMPLICATIONS FOR PRACTICE: Patients had improved quality of life after using the pen to administer insulin. Nurse practitioners should recognize quality of life issues when treating patients with chronic diseases. Nurse practitioners who care for homeless diabetes patients can promote better care for this population by educating homeless shelter staff about diabetes and its management.

Entities:  

Mesh:

Year:  2002        PMID: 12242854     DOI: 10.1111/j.1745-7599.2002.tb00138.x

Source DB:  PubMed          Journal:  J Am Acad Nurse Pract        ISSN: 1041-2972


  10 in total

1.  A qualitative analysis of perceptions and barriers to therapeutic lifestyle changes among homeless hypertensive patients.

Authors:  Leticia R Moczygemba; Amy K Kennedy; Samantha A Marks; Jean-Venable R Goode; Gary R Matzke
Journal:  Res Social Adm Pharm       Date:  2012-07-25

2.  The Effect of Place of Service on Diabetic Screening Adherence in the Homeless Population.

Authors:  Mary Katherine Wainwright; Melinda Earle; Kari Kosog; Mary Kay Gilbert; Christopher Nolan; Ed Stellon; Olivia Vitolo; William Jeffrey Canar
Journal:  J Community Health       Date:  2020-02

Review 3.  What can we learn from patient-reported outcomes of insulin pen devices?

Authors:  Barbara J Anderson; Maria J Redondo
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

Review 4.  Evolution of diabetes insulin delivery devices.

Authors:  Jean-Louis Selam
Journal:  J Diabetes Sci Technol       Date:  2010-05-01

5.  Lessons learned during the development of HumaPen memoir, an insulin pen with a memory feature.

Authors:  Stuart D Breslin; Debra A Ignaut; Douglas E Boyd
Journal:  J Diabetes Sci Technol       Date:  2010-05-01

Review 6.  A review of 20 years' experience with the NovoPen family of insulin injection devices.

Authors:  Jørn Rex; Klaus H Jensen; Simon A Lawton
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 7.  Access to Diabetes Care for Populations Experiencing Homelessness: an Integrated Review.

Authors:  Brandi M White; Ayaba Logan; Gayenell S Magwood
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

Review 8.  A review of 25 years' experience with the NovoPen family of insulin pens in the management of diabetes mellitus.

Authors:  Jacob Hyllested-Winge; Klaus H Jensen; Jørn Rex
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 3.580

Review 9.  Effectiveness of interventions to improve the health and housing status of homeless people: a rapid systematic review.

Authors:  Donna Fitzpatrick-Lewis; Rebecca Ganann; Shari Krishnaratne; Donna Ciliska; Fiona Kouyoumdjian; Stephen W Hwang
Journal:  BMC Public Health       Date:  2011-08-10       Impact factor: 3.295

Review 10.  A Systematic Review of Patients' Perspectives on the Subcutaneous Route of Medication Administration.

Authors:  Colin H Ridyard; Dalia M M Dawoud; Lorna V Tuersley; Dyfrig A Hughes
Journal:  Patient       Date:  2016-08       Impact factor: 3.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.